The Contribution of Bovines to Human Health Against Viral Infections

Overview

Journal Environ Sci Pollut Res Int

Publisher Springer

Specialties Environmental Health
Toxicology

Date 2021 Jul 17

PMID 34272669

Citations 13

Authors

AbdulRahman A Saied

Asmaa A Metwally

Hams M A Mohamed

Mohie A M Haridy

Affiliations

Soon will be listed here.

Abstract

In the last 40 years, novel viruses have evolved at a much faster pace than other pathogens. Viral diseases pose a significant threat to public health around the world. Bovines have a longstanding history of significant contributions to human nutrition, agricultural, industrial purposes, medical research, drug and vaccine development, and livelihood. The life cycle, genomic structures, viral proteins, and pathophysiology of bovine viruses studied in vitro paved the way for understanding the human counterparts. Calf model has been used for testing vaccines against RSV, papillomavirus vaccines and anti-HCV agents were principally developed after using the BPV and BVDV model, respectively. Some bovine viruses-based vaccines (BPIV-3 and bovine rotaviruses) were successfully developed, clinically tried, and commercially produced. Cows, immunized with HIV envelope glycoprotein, produced effective broadly neutralizing antibodies in their serum and colostrum against HIV. Here, we have summarized a few examples of human viral infections for which the use of bovines has contributed to the acquisition of new knowledge to improve human health against viral infections covering the convergence between some human and bovine viruses and using bovines as disease models. Additionally, the production of vaccines and drugs, bovine-based products were covered, and the precautions in dealing with bovines and bovine-based materials.

Citing Articles

Zoonotic Paramyxoviruses: Evolution, Ecology, and Public Health Strategies in a Changing World.

Branda F, Pavia G, Ciccozzi A, Quirino A, Marascio N, Matera G Viruses. 2024; 16(11).

PMID: 39599803 PMC: 11599060. DOI: 10.3390/v16111688.

Impact of the microbiome on human, animal, and environmental health from a One Health perspective.

Ma L, Zhao H, Wu L, Cheng Z, Liu C Sci One Health. 2024; 2:100037.

PMID: 39077043 PMC: 11262275. DOI: 10.1016/j.soh.2023.100037.

The Many Mutations of the COVID-19 Variant: Current Perspectives on EG.5/Eris.

Girma A Environ Health Insights. 2023; 17:11786302231217805.

PMID: 38084254 PMC: 10710748. DOI: 10.1177/11786302231217805.

SARS-CoV-2 antibodies in dogs and cats in a highly infected area of Brazil during the pandemic.

Jarrah S, Kmetiuk L, Valleriani F, Bonfini B, Lorusso A, Vasinioti V Front Vet Sci. 2023; 10:1111728.

PMID: 36908526 PMC: 9995883. DOI: 10.3389/fvets.2023.1111728.

One-Year Surveillance of SARS-CoV-2 Exposure in Stray Cats and Kennel Dogs from Northeastern Italy.

Bellinati L, Campalto M, Mazzotta E, Ceglie L, Cavicchio L, Mion M Microorganisms. 2023; 11(1).

PMID: 36677401 PMC: 9866628. DOI: 10.3390/microorganisms11010110.

References

Ewald P, Swain Ewald H . Infection and cancer in multicellular organisms. Philos Trans R Soc Lond B Biol Sci. 2015; 370(1673). PMC: 4581029. DOI: 10.1098/rstb.2014.0224. View

Vijgen L, Keyaerts E, Moes E, Thoelen I, Wollants E, Lemey P . Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event. J Virol. 2005; 79(3):1595-604. PMC: 544107. DOI: 10.1128/JVI.79.3.1595-1604.2005. View

Pangty K, Singh S, Goswami R, Saikumar G, Somvanshi R . Detection of BPV-1 and -2 and quantification of BPV-1 by real-time PCR in cutaneous warts in cattle and buffaloes. Transbound Emerg Dis. 2010; 57(3):185-96. DOI: 10.1111/j.1865-1682.2009.01096.x. View

Quan F, Vunnava A, Compans R, Kang S . Virus-like particle vaccine protects against 2009 H1N1 pandemic influenza virus in mice. PLoS One. 2010; 5(2):e9161. PMC: 2820088. DOI: 10.1371/journal.pone.0009161. View

Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

August A, Glenn G, Kpamegan E, Hickman S, Jani D, Lu H . A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age. Vaccine. 2017; 35(30):3749-3759. DOI: 10.1016/j.vaccine.2017.05.045. View

Dhama K, Patel S, Sharun K, Pathak M, Tiwari R, Yatoo M . SARS-CoV-2 jumping the species barrier: Zoonotic lessons from SARS, MERS and recent advances to combat this pandemic virus. Travel Med Infect Dis. 2020; 37:101830. PMC: 7396141. DOI: 10.1016/j.tmaid.2020.101830. View

Offit P, Hoffenberg E, Santos N, Gouvea V . Rotavirus-specific humoral and cellular immune response after primary, symptomatic infection. J Infect Dis. 1993; 167(6):1436-40. DOI: 10.1093/infdis/167.6.1436. View

De Clercq E . The design of drugs for HIV and HCV. Nat Rev Drug Discov. 2007; 6(12):1001-18. DOI: 10.1038/nrd2424. View

10.

Ribeiro-Muller L, Muller M . Prophylactic papillomavirus vaccines. Clin Dermatol. 2014; 32(2):235-47. DOI: 10.1016/j.clindermatol.2013.08.008. View

11.

Sok D, Le K, Vadnais M, Saye-Francisco K, Jardine J, Torres J . Rapid elicitation of broadly neutralizing antibodies to HIV by immunization in cows. Nature. 2017; 548(7665):108-111. PMC: 5812458. DOI: 10.1038/nature23301. View

12.

Snowder G, Van Vleck L, Cundiff L, Bennett G . Bovine respiratory disease in feedlot cattle: environmental, genetic, and economic factors. J Anim Sci. 2006; 84(8):1999-2008. DOI: 10.2527/jas.2006-046. View

13.

Beigel J, Voell J, Kumar P, Raviprakash K, Wu H, Jiao J . Safety and tolerability of a novel, polyclonal human anti-MERS coronavirus antibody produced from transchromosomic cattle: a phase 1 randomised, double-blind, single-dose-escalation study. Lancet Infect Dis. 2018; 18(4):410-418. PMC: 5871563. DOI: 10.1016/S1473-3099(18)30002-1. View

14.

Das S, Palmer O, Leight W, Surowitz J, Pickles R, Randell S . Cytokine amplification by respiratory syncytial virus infection in human nasal epithelial cells. Laryngoscope. 2005; 115(5):764-8. DOI: 10.1097/01.MLG.0000159527.76949.93. View

15.

Guzman E, Taylor G . Immunology of bovine respiratory syncytial virus in calves. Mol Immunol. 2015; 66(1):48-56. DOI: 10.1016/j.molimm.2014.12.004. View

16.

Luke T, Wu H, Zhao J, Channappanavar R, Coleman C, Jiao J . Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo. Sci Transl Med. 2016; 8(326):326ra21. DOI: 10.1126/scitranslmed.aaf1061. View

17.

Araldi R, Modolo D, Junior P, Consonni S, de Carvalho R, Roperto F . Genetics and metabolic deregulation following cancer initiation: A world to explore. Biomed Pharmacother. 2016; 82:449-58. DOI: 10.1016/j.biopha.2016.05.031. View

18.

Komoto S, Pongsuwanna Y, Tacharoenmuang R, Guntapong R, Ide T, Higo-Moriguchi K . Whole genomic analysis of bovine group A rotavirus strains A5-10 and A5-13 provides evidence for close evolutionary relationship with human rotaviruses. Vet Microbiol. 2016; 195:37-57. DOI: 10.1016/j.vetmic.2016.09.003. View

19.

Van Doorslaer K . Evolution of the papillomaviridae. Virology. 2013; 445(1-2):11-20. DOI: 10.1016/j.virol.2013.05.012. View

20.

Hartlage A, Cullen J, Kapoor A . The Strange, Expanding World of Animal Hepaciviruses. Annu Rev Virol. 2016; 3(1):53-75. PMC: 5523456. DOI: 10.1146/annurev-virology-100114-055104. View